Embarking on the CAR-T Journey

In this exclusive PC Podcast interview, Renier Brentjens, MD, PhD, deputy director and chair of medicine at the Roswell Park Comprehensive Cancer Center, discusses:

• How he has seen the field evolve since its inception, and what excites him most about its future
• How the Roswell Park expansion helps improve patient access to CAR T-cell therapy
• The key safety concerns associated with CAR T-cell therapy, along with how Roswell Park aims to mitigate potential risks
• How Roswell Park is working to make CAR T-cell therapy more widely available
• The steps needed to be taken at the regulatory and healthcare policy levels in order to support the broader adoption of CAR T-cell therapy

The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.